首页> 外文期刊>Life sciences >New opioid affinity labels containing maleoyl moiety
【24h】

New opioid affinity labels containing maleoyl moiety

机译:含有马来酰基部分的新型阿片样物质亲和标记

获取原文
获取原文并翻译 | 示例
           

摘要

Opioid receptor binding properties and pharmacological profiles of novel peptides containing maleoyl function were determined in order to develop new affinity labels. Based on the enkephalin structure peptide ligands were synthesized and tested. Both in in vitro receptor binding experiments and pharmacological studies, all ligands showed agonist character with relatively high affinity (K_i values in the nanomolar range) and good to moderate selectivity. Replacement of Gly~2 in the enkephalin frame with D-Ala led to higher affinities with a small decrease in selectivity. The loner peptide chains resulted in compounds with high percentage (up to 86%) of irreversible binding. The selectivity pattern of the ligands is in good agreement with the data obtained from the pharmacological assays (guinea pig ileum and mouse vas deferens bioassays). The newly synthesized peptides could be used in further studies in order to determined more detailed characteristics of the ligand-receptor interaction.
机译:确定阿片样物质受体结合特性和含有马来酰功能的新型肽的药理作用,以开发新的亲和标记。基于脑啡肽结构,合成并测试了肽配体。在体外受体结合实验和药理学研究中,所有配体均表现出激动剂特性,具有较高的亲和力(K_i值在纳摩尔范围内)和良好至中等的选择性。用D-Ala取代脑啡肽框架中的Gly〜2导致更高的亲和力,选择性略有下降。孤独的肽链导致化合物具有不可逆结合的高百分比(高达86%)。配体的选择性模式与从药理测定(豚鼠回肠和小鼠输精管生物测定)获得的数据高度吻合。新合成的肽可用于进一步的研究中,以便确定配体-受体相互作用的更详细的特征。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号